Ursodeoxycholic acid therapy in cystic fibrosis—associated liver disease: A dose‐response study
Carla Colombo, Andrea Crosignani, Marisa Assaisso, Pier Maria Battezzati, Mauro Podda, Annamaria Giunta, Linda Zimmer‐Nechemias, Kenneth D. R. Setchell – 1 October 1992 – Previous studies from our groups have demonstrated improvements in biochemical markers of liver function when cystic fibrosis patients with associated liver disease were administered oral ursodeoxycholic acid.